LifeVantage
November 2, 2022
LifeVantage Corporation reported fiscal 2023 first-quarter revenue of 51.8 million dollars, down 2.7 percent from a year earlier and up about 2.3 percent in constant currency. Earnings were 0.05 dollars per diluted share compared with 0.25 dollars, and adjusted EPS was 0.06 dollars. Adjusted EBITDA fell to 2.8 million dollars from 5.8 million dollars.
Active accounts declined 6.7 percent to 153,000. The company ended the quarter with 17.6 million dollars in cash and no debt, and declared a quarterly dividend of 0.03 dollars per share payable December 15.
LifeVantage maintained its fiscal 2023 revenue guidance of 200 million to 212 million dollars. Chief executive Steve Fife pointed to a recent price increase to offset inflation and strong demand for a collagen product launched in June.